138 related articles for article (PubMed ID: 22931492)
1. Quantitative structure-activity relationship study of aromatic inhibitors against rat lens aldose reductase activity using variable selections.
Jung M; Lee Y; Shim M; Lim E; Lee EJ; Lee HC
Med Chem; 2013 May; 9(3):410-9. PubMed ID: 22931492
[TBL] [Abstract][Full Text] [Related]
2. Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection.
Nantasenamat C; Monnor T; Worachartcheewan A; Mandi P; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2014 Apr; 76():352-9. PubMed ID: 24589490
[TBL] [Abstract][Full Text] [Related]
3. Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.
Masand VH; Elsayed NN; Thakur SD; Gawhale N; Rathore MM
Mol Inform; 2019 Aug; 38(8-9):e1800149. PubMed ID: 31131980
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
[TBL] [Abstract][Full Text] [Related]
5. Exploration of QSAR modelling techniques and their combination to rationalize the physicochemical characters of nitrophenyl derivatives towards aldose reductase inhibition.
Soni LK; Gupta AK; Kaskhedikar SG
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1002-7. PubMed ID: 19514863
[TBL] [Abstract][Full Text] [Related]
6. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
Ahmadi S; Ganji S
Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
Jung M; Tak J; Lee Y; Jung Y
Bioorg Med Chem Lett; 2007 Feb; 17(4):1082-90. PubMed ID: 17158047
[TBL] [Abstract][Full Text] [Related]
9. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
10. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure and aldose reductase inhibitory activity relationship of 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone derivatives.
Ko K; Won Y
Bioorg Med Chem; 2005 Mar; 13(5):1445-52. PubMed ID: 15698760
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis.
Moon HI; Jung JC; Lee J
Bioorg Med Chem; 2006 Nov; 14(22):7592-4. PubMed ID: 16870454
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A
Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.
Caballero J
J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibitors from Litchi chinensis Sonn.
Lee SJ; Park WH; Park SD; Moon HI
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):957-9. PubMed ID: 19555177
[TBL] [Abstract][Full Text] [Related]
16. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
[TBL] [Abstract][Full Text] [Related]
17. Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Ishii A; Kotani T; Nagaki Y; Shibayama Y; Toyomaki Y; Okukado N; Ienaga K; Okamoto K
J Med Chem; 1996 Apr; 39(9):1924-7. PubMed ID: 8627616
[TBL] [Abstract][Full Text] [Related]
18. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
Carper DA; Hohman TC; Old SE
Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship of spirosuccinimide type aldose reductase inhibitors diminishing sorbitol accumulation in vivo.
Ko K; Won H; Won Y
Bioorg Med Chem; 2006 May; 14(9):3090-7. PubMed ID: 16412651
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
